Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (351-360 of 372) with videos related to

Pageof 38
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Hepatitis Monthly|November 2, 2016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineSeyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, et al.
Gut|August 22, 2014
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationLindsay Y King, Claudia Canasto-Chibuque, Kara B Johnson, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.
Hepatology (Baltimore, Md.)|June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis BGeorge V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Journal of Hepatology|December 13, 2021
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?Jeffrey V Lazarus, Henry E Mark, Marcela Villota-Rivas, et al.
Journal of Hepatology|February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general populationGeorge V Papatheodoridis, Vana Sypsa, George Dalekos, et al.
Pageof 38

Showing results (351-360 of 372) with videos related to

Sort By:
Pageof 38
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2011
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian WorkshopGiampiero Carosi, Mario Rizzetto, Alfredo Alberti, et al.
Hepatitis Monthly|November 2, 2016
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineSeyed Moayed Alavian, Behzad Hajarizadeh, Kamran Bagheri Lankarani, et al.
Gut|August 22, 2014
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationLindsay Y King, Claudia Canasto-Chibuque, Kara B Johnson, et al.
The Lancet. Gastroenterology & Hepatology|April 8, 2019
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Jean-Frederic Blanc, Jean-Marc Phelip, et al.
JHEP Reports : Innovation in Hepatology|January 16, 2023
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practiceJeffrey V Lazarus, Laurent Castera, Henry E Mark, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.
Hepatology (Baltimore, Md.)|June 17, 2017
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis BGeorge V Papatheodoridis, Ramazan Idilman, George N Dalekos, et al.
Journal of Hepatology|December 13, 2021
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?Jeffrey V Lazarus, Henry E Mark, Marcela Villota-Rivas, et al.
Journal of Hepatology|February 11, 2018
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general populationGeorge V Papatheodoridis, Vana Sypsa, George Dalekos, et al.
Pageof 38